These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 33823532)
1. Deficiency of protease-activated receptor (PAR) 1 and PAR2 exacerbates collagen-induced arthritis in mice via differing mechanisms. Xue M; Lin H; Liang HPH; McKelvey K; Zhao R; March L; Jackson C Rheumatology (Oxford); 2021 Jun; 60(6):2990-3003. PubMed ID: 33823532 [TBL] [Abstract][Full Text] [Related]
2. Activated Protein C Protects against Murine Contact Dermatitis by Suppressing Protease-Activated Receptor 2. Xue M; Lin H; Zhao R; Fryer C; March L; Jackson CJ Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008942 [TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis. Xue M; Chan YK; Shen K; Dervish S; March L; Sambrook PN; Jackson CJ Arthritis Rheum; 2012 Jan; 64(1):88-98. PubMed ID: 21905006 [TBL] [Abstract][Full Text] [Related]
4. Activated protein C targets immune cells and rheumatoid synovial fibroblasts to prevent inflammatory arthritis in mice. Xue M; Dervish S; McKelvey KJ; March L; Wang F; Little CB; Jackson CJ Rheumatology (Oxford); 2019 Oct; 58(10):1850-1860. PubMed ID: 30649471 [TBL] [Abstract][Full Text] [Related]
5. EPCR deficiency ameliorates inflammatory arthritis in mice by suppressing the activation and migration of T cells and dendritic cells. Xue M; Lin H; Liang HPH; Bereza-Malcolm L; Lynch T; Sinnathurai P; Weiler H; Jackson C; March L Rheumatology (Oxford); 2024 Feb; 63(2):571-580. PubMed ID: 37228024 [TBL] [Abstract][Full Text] [Related]
6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of protease-activated receptor 2 in murine models of arthritis. Busso N; Frasnelli M; Feifel R; Cenni B; Steinhoff M; Hamilton J; So A Arthritis Rheum; 2007 Jan; 56(1):101-7. PubMed ID: 17195212 [TBL] [Abstract][Full Text] [Related]
8. Necessity of lysophosphatidic acid receptor 1 for development of arthritis. Miyabe Y; Miyabe C; Iwai Y; Takayasu A; Fukuda S; Yokoyama W; Nagai J; Jona M; Tokuhara Y; Ohkawa R; Albers HM; Ovaa H; Aoki J; Chun J; Yatomi Y; Ueda H; Miyasaka M; Miyasaka N; Nanki T Arthritis Rheum; 2013 Aug; 65(8):2037-47. PubMed ID: 23666827 [TBL] [Abstract][Full Text] [Related]
10. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis. Uusitalo-Jarvinen H; Kurokawa T; Mueller BM; Andrade-Gordon P; Friedlander M; Ruf W Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1456-62. PubMed ID: 17363687 [TBL] [Abstract][Full Text] [Related]
11. Reduction of arthritis severity in protease-activated receptor-deficient mice. Yang YH; Hall P; Little CB; Fosang AJ; Milenkovski G; Santos L; Xue J; Tipping P; Morand EF Arthritis Rheum; 2005 Apr; 52(4):1325-32. PubMed ID: 15818676 [TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model. van den Hengel LG; Hellingman AA; Nossent AY; van Oeveren-Rietdijk AM; de Vries MR; Spek CA; van Zonneveld AJ; Reitsma PH; Hamming JF; de Boer HC; Versteeg HH; Quax PH PLoS One; 2013; 8(4):e61923. PubMed ID: 23637930 [TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction. Friebel J; Weithauser A; Witkowski M; Rauch BH; Savvatis K; Dörner A; Tabaraie T; Kasner M; Moos V; Bösel D; Gotthardt M; Radke MH; Wegner M; Bobbert P; Lassner D; Tschöpe C; Schutheiss HP; Felix SB; Landmesser U; Rauch U Eur Heart J; 2019 Oct; 40(40):3318-3332. PubMed ID: 31004144 [TBL] [Abstract][Full Text] [Related]
15. Human secreted stabilin-1-interacting chitinase-like protein aggravates the inflammation associated with rheumatoid arthritis and is a potential macrophage inflammatory regulator in rodents. Xiao W; Meng G; Zhao Y; Yuan H; Li T; Peng Y; Zhao Y; Luo M; Zhao W; Li Z; Zheng X Arthritis Rheumatol; 2014 May; 66(5):1141-52. PubMed ID: 24470346 [TBL] [Abstract][Full Text] [Related]
16. Diallyl Trisulfide can induce fibroblast-like synovial apoptosis and has a therapeutic effect on collagen-induced arthritis in mice via blocking NF-κB and Wnt pathways. Liang JJ; Li HR; Chen Y; Zhang C; Chen DG; Liang ZC; Shi YQ; Zhang LL; Xin L; Zhao DB Int Immunopharmacol; 2019 Jun; 71():132-138. PubMed ID: 30897500 [TBL] [Abstract][Full Text] [Related]
17. Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. Li J; Guo Y; Holmdahl R; Ny T Arthritis Rheum; 2005 Aug; 52(8):2541-8. PubMed ID: 16052596 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-21 signaling in B cells, but not in T cells, is indispensable for the development of collagen-induced arthritis in mice. Sakuraba K; Oyamada A; Fujimura K; Spolski R; Iwamoto Y; Leonard WJ; Yoshikai Y; Yamada H Arthritis Res Ther; 2016 Aug; 18():188. PubMed ID: 27535236 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of glycogen synthase kinase-3β suppresses inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes and collagen-induced arthritis. Kwon YJ; Yoon CH; Lee SW; Park YB; Lee SK; Park MC Joint Bone Spine; 2014 May; 81(3):240-6. PubMed ID: 24176738 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of collagen induced arthritis via suppression on Th17 response by activating cholinergic anti-inflammatory pathway with nicotine. Wu S; Luo H; Xiao X; Zhang H; Li T; Zuo X Eur J Pharmacol; 2014 Jul; 735():97-104. PubMed ID: 24755145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]